01:14 , Aug 2, 2019 |  BC Extra  |  Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

Nektar gains after FDA breakthrough therapy designation  Nektar Therapeutics Inc. (NASDAQ:NKTR) was up $2.73 (10%) to $31.19 after FDA granted breakthrough designation for bempegaldesleukin (NKTR-214) in combination with Opdivo nivolumab from Bristol-Myers Squibb Co. (NYSE:BMY)...
08:00 , Dec 14, 2015 |  BC Week In Review  |  Company News

Bioaster, Cancer Research Center of Lyon, J&J deal

Bioaster, the center and Johnson & Johnson’s Janssen-Cilag S.A.S. company partnered to conduct preclinical R&D of immunotherapeutic treatments for chronic HBV infection. The deal term is two years. Bioaster , Lyon, France   Cancer Research...
08:00 , Nov 16, 2015 |  BC Week In Review  |  Company News

Fujifilm, Bioaster deal

Fujifilm and technology research institute Bioaster partnered non-exclusively to study a portable Ebola virus diagnostic. The diagnostic will use Fujifilm’s virus detection technology with Ebola virus antibodies produced and evaluated by Bioaster. Experts from Bioaster...